Conagra Brands vs Kenvue
Side-by-side comparison of AI visibility scores, market position, and capabilities
Chicago packaged frozen food brands (NYSE: CAG) ~$11.9B FY2025 revenue; Birds Eye 40%+ frozen veggie share, Slim Jim #1 convenience meat snack, Pinnacle Foods acquisition 2018 competing with Nestlé and General Mills.
About
Conagra Brands, Inc. is a Chicago, Illinois-based packaged food company — publicly traded on the New York Stock Exchange (NYSE: CAG) as an S&P 500 Consumer Staples component — marketing a portfolio of branded consumer foods and foodservice products including frozen meals (Birds Eye, Healthy Choice, Marie Callender's, Banquet), condiments and sauces (Hunt's, Slim Jim, Duncan Hines, Vlasic), snacks (Angie's BOOM CHICKA POP, Bigs seeds, Orville Redenbacher's), and international brands through approximately 18,000 employees. In fiscal year 2025 (ending May 2025), Conagra reports revenues of approximately $11.9 billion, navigating consumer trade-down behavior (consumers buying fewer premium branded frozen meals and choosing lower-price options or home-cooked meals) and competitive private label penetration in frozen meal categories (Birds Eye, Healthy Choice, and Marie Callender's facing increased competition from Kroger, Walmart, and Costco private label frozen meal options priced 20-30% below branded alternatives). CEO Sean Connolly has executed Conagra's "Conagra Way" transformation: divesting commodity businesses (Lamb Weston potato processing — spun off as independent public company in 2016; private label operations sold) and building the brand portfolio through the 2018 acquisition of Pinnacle Foods ($10.9 billion — adding Birds Eye, Duncan Hines, Vlasic, and Gardein plant-based foods) — concentrating Conagra's capital and marketing investment on premium branded frozen and packaged food categories where Conagra holds #1 or #2 market share positions. Conagra's frozen vegetable leadership (Birds Eye — 40%+ US frozen vegetable market share) and frozen meal portfolio (Healthy Choice café steamers, Marie Callender's pot pies and dinners) position the company in categories that benefit from the "cooking-at-home" preference when dining out costs rise.
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
About
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.